Abstract #1699

Metabolic biomarkers associated with occurrence of hepatocellular carcinoma in patients with liver cirrhosis: in vivo 1H magnetic resonance spectroscopy

Chung Man Moon^1,2, Sang Soo Shin^2,3, Yong Yeon Jeong^2,4, and Suk Hee Heo^2,4

¹National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, United States, ²Radiology, Chonnam National University Medical School, Gwangju, Korea, Republic of, ³Radiology, Chonnam National University Hospital, Gwangju, Korea, Republic of, ⁴Radiology, Chonnam National University Hwasun Hospital, Gwangju, Korea, Republic of

Liver cirrhosis (LC) secondary to chronic hepatitis can lead to serious complications. More severely, liver cirrhotic patients may eventually develop hepatocellular carcinoma (HCC), thus monitoring disease progression is clinically important. The purpose of this study was to investigate the utility of ¹H magnetic resonance spectroscopy (¹H-MRS) with long echo time to quantify the differences in hepatic metabolites of normal, cirrhotic liver with and without HCC, and HCC. These findings would be helpful for understanding of liver metabolic changes related with developing HCC in the cirrhotic liver.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.